The role of TandemHeart™ combined with ProtekDuo™ as right ventricular support device

Beatrice De Lazzari, Roberto Badagliacca, Massimo Capoccia, Marc O Maybauer, Claudio De Lazzari. DOI: 10.1016/j.cmpb.2024.108473

Abstract: Right ventricular failure increases short-term mortality in the setting of acute myocardial infarction, cardiogenic shock, advanced left-sided heart failure and pulmonary arterial hypertension. Percutaneous and surgically implanted right ventricular assist devices (RVAD) have been investigated in different clinical settings. The use of the ProtekDuo™ is currently a promising approach due to its features such as groin-free approach leading to early mobilisation, easy percutaneous deployment, compatibility with different pumps and oxygenators, and adaptability to different configurations. The aim of this work was to simulate the behaviour of the TandemHeart™ pump applied "in series" and "in parallel" mode and the combination of TandemHeart™ and ProtekDuo™ cannula as RVAD using CARDIOSIM© software simulator platform.

Previous
Previous

You are safe here: A flyer with re-orientating messages for families of patients with delirium in ICU

Next
Next

An ovine septic shock model of live bacterial infusion